Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.500
+0.090 (6.38%)
Jan 8, 2026, 12:11 PM EST - Market open
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $35.15 million as of January 8, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
35.15M
Enterprise Value
21.63M
1-Year Change
-63.74%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $35.15M, a decrease of -83.16%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 33.04M | -5.37% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.06B |
| Johnson & Johnson | 497.11B |
| AbbVie | 394.78B |
| UnitedHealth Group | 315.87B |
| AstraZeneca | 280.51B |
| Merck & Co. | 272.40B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |